News
Klose’s work on tularemia with its prototype vaccine platform may have direct applicability to COVID-19, as both are respiratory illnesses caused by inhaling microbes into the lung. Klose’s vaccine ...
A review of recent findings suggests that Appili's biodefense vaccine, ATI-1701, may have a role in preventing tularemia ...
At present, a "live vaccine strain" (LVS) tularemia vaccine is under investigational new drug (IND) status in a protocol at the US Army Medical Research Institute of Infectious Diseases (USAMRIID ...
Tularemia killed several squirrels in Champaign, and a rabbit in Douglas County. Stream NBC 5 for free, 24/7, wherever you are. It’s most commonly spread through contact with infected animals ...
“Appili is developing ATI-1701, a biodefense vaccine, to protect warfighters from tularemia,” said Dr. Carl Gelhaus, Director of Non Clinical Research at Appili Therapeutics. “Together with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results